What should ethics guidelines look like for clinical trials of in utero stem cell, protein, mRNA, and gene therapies to treat fetal disease?
{{output}}
State-of-the-art minimally invasive in utero interventions involving stem cell, protein, and nucleic acid-based therapies represent a new frontier in medicine, which offers hope for devastating fetal diagnoses and promises the restoration of lifetimes. Yet the... ...
